Bendamustine HCl for Injection

Active Ingredients: Bendamustine HCl

Bendamustine HCl for Injection is an antineoplastic drug used in chemotherapy treatment for certain cancers of the blood. It is indicated for the treatment of chronic lymphocytic leukemia. It is also used to treat indolent non-Hodgkin's lymphoma that has been unresponsive to other treatments.

Bendamustine Hydrochloride is classified as an alkylating agent. It works by alkylating (adding an alkyl group) and cross-linking DNA, which causes DNA fragmentation, inhibition of protein synthesis, and cell death.

AdvaCare is a GMP manufacturer of Bendamustine HCl for Injection. We distribute a wide range of high-quality and cost-effective oncology medications. These medications have been manufactured in our facilities in China, India, and the USA.

AdvaCare Pharma manufactures Bendamustine Injection, one of 40+ oncology treatments, according to rigorous GMP protocols at our state-of-the-art production facility. We are committed to producing quality-assured, cost-effective cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. As an established Bendamustine manufacturer, we supply pharmaceutical distributors, hospitals and government institutions with reliable cancer drugs.

What is Bendamustine HCl used for?

How should Bendamustine HCl Powder for Injection be used?

This medication is manufactured as a powder and stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by slow injection into a vein.

As Bendamustine Hydrochloride for Injection is a cytotoxic drug, caution should be used when preparing and administering the solution. Goggles, gloves, and protective gowns are recommended.

What dosage should be used?

For chronic lymphocytic leukemia (CLL), the usual dose is 100mg/m² per dose, given on days 1 and 2 of a 28 day cycle. The cycle can be repeated up to 6 times.

For indolent B-cell non-Hodgkin lymphoma, the usual dose is 120mg/m² per dose, given on days 1 and 2 of a 28 day cycle. The cycle can be repeated up to 8 times.

However, the exact dosage is dependent on the patient and treatment plan, refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

As with all pharmaceuticals, some unwanted effects can occur from the use of Bendamustine HCl for Injection.

For a comprehensive list of all possible effects, consult a doctor.

If any symptoms persist or worsen, or you notice any other symptoms, please call your doctor immediately.

Do NOT use Bendamustine HCl for Injection if: • You are allergic to any component of the powder.

Consult with a doctor about any medications you are taking before treatment with Bendamustine HCl for Injection. This drug is known to interact with allopurinol, as well as other medications.

Do not take Bendamustine Hydrochloride during pregnancy, as it may cause birth defects. It is important for both women and men being treated with this drug to use an effective method of birth control. For women, continue birth control for at least 6 months after treatment, and at least 3 months after treatment for men. Inform a doctor as soon as possible if pregnancy occurs during treatment with Bendamustine HCl. Do not breastfeed for at least 1 week after treatment.

Driving or operating machinery should be safe, as the medication not cause any relevant symptoms, but individual reactions to the medication may vary.